Keyphrases
Area Index
20%
Atopic Dermatitis
100%
Atopic Eczema
18%
Autoimmune Blistering Diseases
5%
Basal Cell Carcinoma
8%
Clinical Practice
16%
Clinical Presentation
5%
Clinical Signs
9%
Clinical Trials
31%
Confidence Interval
6%
Consensus Statement
12%
Core Outcome Measures
9%
Core Outcome Set
17%
Dermatitis
8%
Dermatologist
5%
Dupilumab
14%
Eczema
71%
Healthcare Professionals
5%
Immunosuppression
6%
Impact Scale
8%
Index Score
5%
International Consensus Meeting
8%
Investigator's Global Assessment
9%
Israel
10%
Itch
12%
Long-term Control
6%
Malignancy
6%
Meta-analysis
22%
Mycosis Fungoides
8%
Numerical Rating Scale
10%
Opportunistic Infections
5%
Pemphigus
43%
Pemphigus Foliaceus
5%
Pemphigus Vulgaris
6%
Placebo
11%
Practical Guide
8%
Pruritus
10%
Psoriasis
5%
Quality of Life
6%
Real-world Experience
12%
Remission
9%
Risk Factors
6%
Rituximab
22%
SCORing Atopic Dermatitis (SCORAD)
5%
Severity Index
20%
Symptom Scale
8%
Systematic Literature Review
8%
Systematic Meta-analysis
21%
Tertiary Care Hospital
5%
Topical Corticosteroids
8%
Medicine and Dentistry
Atopic Dermatitis
72%
Basal-Cell Carcinoma
8%
Cancer
6%
Clinical Trial
14%
Cohort Analysis
5%
Cross Sectional Study
5%
Dermatitis
5%
Dermatology
10%
Diseases
9%
Dupilumab
9%
Eczema
22%
Meta-Analysis
17%
Methotrexate
5%
Mycosis fungoides
8%
Numeric Rating Scale
9%
Opportunistic Infection
8%
Pemphigus
25%
Placebo
8%
Pruritus
11%
Rituximab
5%
Scalp
5%
Side Effect
7%
Systematic Review
35%
Tacrolimus
5%
Topical Corticosteroid
7%